The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
Open accessThe DOI matches its Crossref record; 254 of the 256 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) represents a progressive amyloidogenic disorder whose advancement is widely recognized to be connected to amyloid-β peptides and Tau aggregation. However, several other processes likely contribute to the development of AD and some of them might be related to protein-protein interactions. Amyloid aggregates usually contain not only single type of amyloid protein, but also other type of proteins and this phenomenon can be rationally explained by the process of protein cross-seeding and co-assembly. Amyloid cross-interaction is ubiquitous in amyloid fibril formation and so a better knowledge of the amyloid interactome could help to further understand the mechanisms of amyloid related diseases. In this review, we discuss about the cross-interactions of amyloid-β peptides, and in particular Aβ1-42, with other amyloids, which have been presented either as integrated part of Aβ neurotoxicity process (such as Tau) or conversely with a preventive role in AD pathogenesis by directly binding to Aβ (such as transthyretin, cystatin C and apolipoprotein A1). Particularly, we will focus on all the possible therapeutic strategies aiming to rescue the Aβ toxicity by taking inspiration from these protein-protein interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6 (A) Interaction structure of the CysC-Aβ complex revealed by molecular dynamics simulation in the study of Przybylski et al. [186] (B) The binding complex from the docking output between Aβ and CysC fragment in the study of Sharma et al. [188].](https://figures.cochat.ai/paper-figures/bbab80daba5a471099eedf3fad19f17e/the-positive-side-of-the-alzheimers-disease-amyloid-cross-interactions-the-case-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, the interaction between Aβ and transthyretin (TTR) is a favored PPI, because it reduces Aβ aggregation and toxicity.588”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [588]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–254 of 254
Juszczyk, P., Paraschiv, G., Szymanska, A., Kolodziejczyk, A. S., Rodziewicz-Motowidlo, S., Grzonka, Z., & Przybylski, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801115e · Cited by 51
Haan, J., Maat-Schieman, M. L. C., Duinen, S. G., Jensson, O., Thorsteinsson, L., & Roos, R. A. C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb02648.x · Cited by 51 · cited 3×
“The co-localization of CysC and Aβ has been observed in the cerebral arteries of patients affected by cerebral amyloid angiopathy (CAA) [174], in parenchymal and vascular amyloid deposits in brains of patients with Alzheimer disease [175] and in sporadic inclusion-body myositis (sIBM) muscle fibers [176].”
BackgroundMapping the Structural Transition in an Amyloidogenic Apolipoprotein A-I
Lagerstedt, J. O., Cavigiolio, G., Roberts, L., Hong, H., Jin, L., FitzGerald, P. G., Oda, M. N., & Voss, J. C. (2007) · Biochemistry · doi:10.1021/bi7005493 · Cited by 50 · cited 2×
“Studies with electron paramagnetic resonance spectroscopy [219], X-ray crystallographic studies [220] and hydrogen-deuterium exchange mass spectroscopy [221] showed that the G26R mutation induces helix destabilization of the protein in the N-terminal domain leading to a transition of residues 14-58 to a β-sheet confor…”
BackgroundCystatin C as a risk factor for Alzheimer disease
Cathcart, H. M., Huang, R., Lanham, I. S., Corder, E. H., & Poduslo, S. E. (2005) · Neurology · doi:10.1212/01.wnl.0000151980.42337.44 · Cited by 48 · cited 1×
“Experimental data suggested a synergistic association among the CST3-A allele, APOE4 and AD in elderly AD patients [179,180].”
BackgroundAlzheimer's Disease Is the Most Common Neurodegenerative Disorder
Selkoe, D. J., & Lansbury, P. T. (1999) · Cited by 47
Tripathi, T., & Khan, H. (2020) · Biochemistry · doi:10.1021/acs.biochem.9b01087 · Cited by 45 · cited 1×
“All these results open the hypothesis of a pathological cross-seeding via a shared epitope between Aβ and Tau [99].”
BackgroundAmyloid Formation by Transthyretin: From Protein Stability to Protein Aggregation
Brito, R. M. M., Damas, A. M., & Saraiva, M. J. (2003) · Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents · doi:10.2174/1568013033483230 · Cited by 44 · cited 2×
“Familial amyloid polyneuropathy (FAP) is another TTR amyloidosis and is usually associate to Val30Met point mutation [106].”
BackgroundCiccone, L., Tonali, N., Nencetti, S., & Orlandini, E. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1760262 · Cited by 43 · cited 1×
“One therapeutic strategy against TTR amyloidosis is the tetramer stabilization by small molecules such as bisaryl [109,110] or monoaryl [111–113] structure-based compounds or natural molecules [114,115].”
BackgroundSelf-citationTransthyretin-Derived Peptides as β-Amyloid Inhibitors
Cho, P. Y., Joshi, G., Johnson, J. A., & Murphy, R. M. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500014u · Cited by 42 · cited 1×
“They identified a linear peptide (G16) able to bind Aβ and reduce its toxicity in a dose-dependent manner, even if it increased the average size of Aβ aggregates, unlike wild-type TTR [152] (Figure 4).”
BackgroundSingle-Molecule Imaging Reveals Aβ42:Aβ40 Ratio-Dependent Oligomer Growth on Neuronal Processes
Johnson, R. D., Schauerte, J. A., Chang, C.-C., Wisser, K. C., Althaus, J. C., Carruthers, C. J. L., Sutton, M. A., Steel, D. G., & Gafni, A. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.12.051 · Cited by 41
Fernández-de Retana, S., Montañola, A., Marazuela, P., De La Cuesta, M., Batlle, A., Fatar, M., Grudzenski, S., Montaner, J., & Hernández-Guillamon, M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.028 · Cited by 41 · cited 22×
“It has been proved for example that transgenic mice expressing high level of Aβ1-40 do not develop Aβ plaque [92] and that Aβ1-40 stabilizes Aβ1-42 monomers by competing for binding site on pre-existing Aβ1-42 aggregates, thus inhibiting further aggregation [93].”
BackgroundInfluentialElectrochemical and Conformational Consequences of Copper (CuI and CuII) Binding to β‐Amyloid(1–40)
Brzyska, M., Trześniewska, K., Wieckowska, A., Szczepankiewicz, A. A., & Elbaum, D. (2009) · ChemBioChem · doi:10.1002/cbic.200800732 · Cited by 40
Stoekenbroek, R. M., Stroes, E. S. G., & Hovingh, G. K. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_21 · Cited by 39
Copper mediated amyloid-β binding to Transthyretin
Ciccone, L., Fruchart‐Gaillard, C., Mourier, G., Savko, M., Nencetti, S., Orlandini, E., Servent, D., Stura, E. A., & Shepard, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-31808-5 · Cited by 39 · cited 1×
“5 mM) and the results showed that the affinity of TTR for Aβ (1–28) is modulated by copper [138].”
BackgroundSelf-citationVattemi, G., King Engel, W., McFerrin, J., & Askanas, V. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01798.x · Cited by 37 · cited 1×
“The co-localization of CysC and Aβ has been observed in the cerebral arteries of patients affected by cerebral amyloid angiopathy (CAA) [174], in parenchymal and vascular amyloid deposits in brains of patients with Alzheimer disease [175] and in sporadic inclusion-body myositis (sIBM) muscle fibers [176].”
BackgroundFitz, N. F., Tapias, V., Cronican, A. A., Castranio, E. L., Saleem, M., Carter, A. Y., Lefterova, M., Lefterov, I., & Koldamova, R. (2015) · Brain · doi:10.1093/brain/awv293 · Cited by 37 · cited 1×
“Moreover, an increase of plasma levels of Aβ1-42 and an aggravation of memory deterioration impacting negatively dendrite architecture have been also identified in KO ApoA1/ApoE mice, suggesting an important role of more than one apolipoprotein in the Aβ1-42 clearance [235].”
BackgroundStructure-activity relationships of β-hairpin mimics as modulators of amyloid β-peptide aggregation
Tonali, N., Kaffy, J., Soulier, J. L., Gelmi, M. L., Erba, E., Taverna, M., van Heijenoort, C., Ha‐Duong, T., & Ongeri, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.05.018 · Cited by 37
Self-citationHua, Y., Zhao, H., Lu, X., Kong, Y., & Jin, H. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.672502 · Cited by 35 · cited 1×
“The result showed tha the CST3 G73A polymor hi m is associated with AD in Caucasian populations, but not in Asians [178].”
Complexes of Amyloid-β and Cystatin C in the Human Central Nervous System
Mi, W., Jung, S. S., Yu, H., Schmidt, S. D., Nixon, R. A., Mathews, P. M., Tagliavini, F., & Levy, E. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1147 · Cited by 34 · cited 2×
“normal displayed a drastic decrease in Aβ fibril deposition [184].”
BackgroundNMR Meets Tau: Insights into Its Function and Pathology
Lippens, G., Landrieu, I., Smet, C., Huvent, I., Gandhi, N., Gigant, B., Despres, C., Qi, H., & Lopez, J. (2016) · Biomolecules · doi:10.3390/biom6020028 · Cited by 34
Ikezu, S., Dixie, K. L. I., Koro, L., Watanabe, T., Kaibuchi, K., & Ikezu, T. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0890-4 · Cited by 33
Girych, M., Gorbenko, G. P., Trusova, V. M., Adachi, E., Mizuguchi, C., Nagao, K., Kawashima, H., Akaji, K., Lund‐Katz, S., Phillips, M. C., et al. (2013) · Journal of Structural Biology · doi:10.1016/j.jsb.2013.10.017 · Cited by 31
Gimeno, A., Santos, L. M., Alemi, M., Rivas, J., Blasi, D., Cotrina, E. Y., Llop, J., Valencia, G., Cardoso, I., Quintana, J. R., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00428 · Cited by 31 · cited 4×
“Successively, starting from these results, the research group continued to go deeply insight by exploring the biodistribution features of IDIF by radiolabeled techniques [144], the thermodynamic characteristics of the formation of binary (Aβ/TTR) and trinary (Aβ/TTR/IDIF) complexes by calorimetric studies in compariso…”
BackgroundInfluentialTau Derived Hexapeptide AcPHF6 Promotes Beta-Amyloid (Aβ) Fibrillogenesis
Mohamed, T., Gujral, S. S., & Rao, P. P. N. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00433 · Cited by 31 · cited 1×
“The N-acetylated and C-amidated PHF6 (Ac-VQIVYK-NH2) drastically promotes the aggregation of both Aβ1-40 and Aβ1-42 but at the same time it is able to reduce cellular toxicity mediated by Aβ1-40 and Aβ1-42 in hippocampal neuronal cell line (HT22) [96].”
BackgroundTonali, N., Dodero, V. I., Kaffy, J., Hericks, L., Ongeri, S., & Sewald, N. (2019) · ChemBioChem · doi:10.1002/cbic.201900652 · Cited by 31
Self-citationA Cyclic Peptide Mimic of the β-Amyloid Binding Domain on Transthyretin
Cho, P. Y., Gururaj Joshi, A., Boersma, M., Johnson, J. A., & Murphy, R. M. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500272a · Cited by 30 · cited 1×
“The imposition of structural constraints generated a much improved peptidomimetic of the Aβ binding epitope on TTR (cG3, Figure 3) [153].”
BackgroundTransthyretin Mimetics as Anti‐β‐Amyloid Agents: A Comparison of Peptide and Protein Approaches
Pate, K. M., Kim, B. J., Shusta, E. V., & Murphy, R. M. (2018) · ChemMedChem · doi:10.1002/cmdc.201800031 · Cited by 30 · cited 4×
“It is hypothesized that the greater efficacy of mTTR is attributable to a relative stable anti-parallel two β-strand conformation that fully mimics TTR’s Aβ binding site, while cG8 shows a conformational heterogeneity [155].”
BackgroundInfluentialQuintela, T., Alves, C. H., Gonçalves, I., Baltazar, G., Saraiva, M. J., & Santos, C. R. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.095 · Cited by 29
TTR Fibril Formation Inhibitors: Is there a SAR?
Nencetti, E. O. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800269326 · Cited by 29 · cited 1×
“One therapeutic strategy against TTR amyloidosis is the tetramer stabilization by small molecules such as bisaryl [109,110] or monoaryl [111–113] structure-based compounds or natural molecules [114,115].”
BackgroundChetty, P. S., Ohshiro, M., Saito, H., Dhanasekaran, P., Lund‐Katz, S., Mayne, L. C., Englander, W., & Phillips, M. C. (2012) · Biochemistry · doi:10.1021/bi300926j · Cited by 28 · cited 2×
“Studies with electron paramagnetic resonance spectroscopy [219], X-ray crystallographic studies [220] and hydrogen-deuterium exchange mass spectroscopy [221] showed that the G26R mutation induces helix destabilization of the protein in the N-terminal domain leading to a transition of residues 14-58 to a β-sheet confor…”
BackgroundRojas, A. V., Maisuradze, G. G., & Scheraga, H. A. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b04647 · Cited by 28 · cited 21×
“It has been proved for example that transgenic mice expressing high level of Aβ1-40 do not develop Aβ plaque [92] and that Aβ1-40 stabilizes Aβ1-42 monomers by competing for binding site on pre-existing Aβ1-42 aggregates, thus inhibiting further aggregation [93].”
BackgroundInfluentialCotrina, E. Y., Gimeno, A., Llop, J., Jiménez‐Barbero, J., Quintana, J. R., Valencia, G., Cardoso, I., Prohens, R., & Arsequell, G. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01970 · Cited by 28 · cited 1×
“Successively, starting from these results, the research group continued to go deeply insight by exploring the biodistribution features of IDIF by radiolabeled techniques [144], the thermodynamic characteristics of the formation of binary (Aβ/TTR) and trinary (Aβ/TTR/IDIF) complexes by calorimetric studies in compariso…”
BackgroundReview on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors
Guo, X., Liu, Z., Zheng, Y., Li, Y., Li, L., Liu, H., Chen, Z., & Wu, L. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s237252 · Cited by 28 · cited 1×
“One therapeutic strategy against TTR amyloidosis is the tetramer stabilization by small molecules such as bisaryl [109,110] or monoaryl [111–113] structure-based compounds or natural molecules [114,115].”
BackgroundQuintela, T., Gonçalves, I., Martinho, A., Alves, C. H., Saraiva, M. J., Rocha, P., & Santos, C. R. A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9398-x · Cited by 27
Ríos, X., Gómez‐Vallejo, V., Martín, A., Cossío, U., Morcillo, M. Á., Alemi, M., Cardoso, I., Quintana, J. R., Jiménez‐Barbero, J., Cotrina, E. Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50071-w · Cited by 24 · cited 1×
“Successively, starting from these results, the research group continued to go deeply insight by exploring the biodistribution features of IDIF by radiolabeled techniques [144], the thermodynamic characteristics of the formation of binary (Aβ/TTR) and trinary (Aβ/TTR/IDIF) complexes by calorimetric studies in compariso…”
BackgroundMizuguchi, C., Nakagawa, M., Namba, N., Sakai, M., Kurimitsu, N., Suzuki, A., Fujita, K., Horiuchi, S., Baba, T., Ohgita, T., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008000 · Cited by 23 · cited 4×
“Using circular dichroism, they also showed that the fragment 14–22 allows β-transition and fibrilization [216].”
BackgroundInfluentialTANGO-Inspired Design of Anti-Amyloid Cyclic Peptides
Lü, X., Brickson, C., & Murphy, R. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00150 · Cited by 22 · cited 2×
“accelerating the Aβ clearance by natural mechanisms [154].”
BackgroundPietropaolo, A., Satriano, C., Strano, G., Mendola, D. L., & Rizzarelli, E. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.08.013 · Cited by 20
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds
Ortore, G., Orlandini, E., Braca, A., Ciccone, L., Rossello, A., Martinelli, A., & Nencetti, S. (2016) · ChemMedChem · doi:10.1002/cmdc.201600092 · Cited by 20 · cited 1×
“One therapeutic strategy against TTR amyloidosis is the tetramer stabilization by small molecules such as bisaryl [109,110] or monoaryl [111–113] structure-based compounds or natural molecules [114,115].”
BackgroundSelf-citationStructural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils
Castro-Rodrigues, A. F., Gales, L., Saraiva, M. J., & Damas, A. M. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744491104491x · Cited by 17 · cited 1×
“It has been reported that the same cations interact with TTR [136,137].”
BackgroundSynthesis, transport, and processing of apolipoproteins of high density lipoproteins
Stoffel, W. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34436-9 · Cited by 17
Ciccone, L., Nencetti, S., Rossello, A., Stura, E. A., & Orlandini, E. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1167048 · Cited by 17
Self-citationHuman TTR conformation altered by rhenium tris-carbonyl derivatives
Ciccone, L., Policar, C., Stura, E. A., & Shepard, W. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2016.07.002 · Cited by 17 · cited 1×
“5 Å in one T4-BP, while decreased in the other probably due to the rhenium binding [139].”
BackgroundSelf-citationTonali, N., Correia, I., Lesma, J., Bernadat, G., Ongeri, S., & Lequin, O. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob02654a · Cited by 17 · cited 2×
“This consideration opens the way to the use of peptidomimetic foldamers, for example, as a new approach which might resolve a major issue in the use of peptides as drugs, by stabilizing secondary conformations similar to natural peptides and retaining the selectivity due to the lateral chains [156].”
BackgroundSelf-citationWang, B., Xie, Y.-C., Yang, Z., Peng, D., Wang, J., Zhou, S., Li, S., & Ma, X. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000125670 · Cited by 15 · cited 1×
“In a studied published in 2008, it was reported that, in Mainland Chinese patients and the healthy controls no statistical difference exists between CST3 genotype and allele frequencies [177].”
BackgroundCiccone, L., Nencetti, S., Rossello, A., Tepshi, L., Stura, E. A., & Orlandini, E. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1070265 · Cited by 14
Self-citation(2011) · Drugs in R&D · doi:10.1007/bf03259808 · Cited by 14
Protein Chemistry of Amyloid Fibrils and Chaperones: Implications for Amyloid Formation and Disease
Yerbury, J. J., & Kumita, J. R. (2010) · Current Chemical Biology · doi:10.2174/187231310791170810 · Cited by 13 · cited 2×
“Molecular chaperones represent the most important elements of the ensemble of machinery responsible for protein homeostasis [14].”
BackgroundSpodzieja, M., Kalejta, K., Kołodziejczyk, A. S., Maszota‐Zieleniak, M., Rodziewicz‐Motowidło, S., Żmudzińska, W., & Czaplewska, P. (2016) · Journal of Molecular Recognition · doi:10.1002/jmr.2581 · Cited by 9 · cited 1×
“Structural studies by circular dichroism and NMR conducted on CysC 101–117 fragment demonstrated the absence of a well-defined structure with a weak tendency to bend in the middle part of the sequence [187].”
BackgroundSynthesis and physicochemical studies of amyloidogenic hexapeptides derived from human cystatin C
Iłowska, E., Sawicka, J., & Szymańska, A. (2018) · Journal of Peptide Science · doi:10.1002/psc.3073 · Cited by 7 · cited 1×
“In the protein structure (3GAX), this fragment is located in the first hairpin and consists of sequences of β-strands 2 and 3 and the loop L1 which connects these strands [189].”
Background[38] Mapping protein conformations in fibril structures using monoclonal antibodies
Lundgren, E., Persson, H., Andersson, K., Olofsson, A., Dacklin, I., & Goldsteins, G. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09040-0 · Cited by 6 · cited 1×
“The fibril formation pathway is analogue to that suggested for other amyloidogenic proteins: a single point mutation is responsible of a conformational change which leads to expose hydrophobic surfaces promoting the self-association and thus the fibril deposition [166,167].”
Background[EC‐03–02]: CRYO‐EM STRUCTURES OF TAU FILAMENTS FROM ALZHEIMER'S DISEASE BRAIN
Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G. N., Garringer, H. J., Crowther, A. R., Ghetti, B. F., Goedert, M., & Scheres, S. H. W. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.07.298 · Cited by 4
Transthyretin amyloidosis: an over review
(2015) · Cardiovascular Regenerative Medicine · doi:10.14800/crm.952 · Cited by 3 · cited 1×
“Familial amyloid cardiomyopathy (FAC) is a rare autosomal-dominant disease associated to the deposition of TTR amyloid plaques in the myocardium [107] and related to the most common TTR mutation Val122Ile [108].”
BackgroundA computational examination of the binding interactions of amyloidβ and human cystatin C
Sharma, A. K., Persichetti, J., Tale, E., Prelvukaj, G., Cropley, T. C., & Choudhury, R. (2017) · Journal of Theoretical and Computational Chemistry · doi:10.1142/s0219633618500013 · Cited by 2 · cited 2×
“During all the simulation, Aβ explores different conformational rearrangements with a major secondary structure element being an α-helix, contrary to CysC whose secondary structures revealed a relative rigidity with a preserved β-sheet as representative structure (Figure 6B) [188].”
Background
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Jiménez-Balado, J., & Eich, T. S. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 183
“Recent work suggests that tau and Aβ are interconnected, and together trigger the neurodegeneration in the brain that ultimately results in AD [18-20].”
BackgroundLimorenko, G., & Lashuel, H. A. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 162
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease
Barmaki, H., Nourazarian, A., & Khaki-Khatibi, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281338 · Cited by 87
Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
Fang, Y., Wang, J., Zhao, M., Zheng, Q., Ren, C., Wang, Y., & Zhang, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00844 · Cited by 100
Metadata
- Authors
- Ciccone, L., Shi, C., di Lorenzo, D., Van Baelen, A.-C., & Tonali, N.
- Affiliations
- University of Pisa (IT)
- Centre National de la Recherche Scientifique (FR)
- CNRS, BioCIS, Université Paris-Saclay, rue Jean-Baptiste Clément 5, 92290 Châtenay-Malabry, France
- Département Médicaments et Technologies pour la Santé (DMTS), CEA, INRAE, Université Paris Saclay, SIMoS, 91191 Gif-sur-Yvette, France
- Corresponding author
- Ciccone, Lidia
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-05-23
- Volume
- 25
- Issue
- 10
- Pages
- 2439
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7288020
- OpenAlex
- W3027358274
- Cited by
- 69
- References
- 256
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 6 · 2023: 11 · 2022: 11 · 2021: 15 · 2020: 5
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Horizon 2020 (860070)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta 42, co-assembly, protein-protein interaction, tau aggregation, prealbumin, cystatin C, apolipoprotein A-I, treatment options
- MeSH terms
- Alzheimer Disease, Amyloid, Humans, Peptide Fragments, Prealbumin, Amyloid beta-Peptides, Apolipoprotein A-I, tau Proteins, Cystatin C, Protein Interaction Maps, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.